首页> 外文期刊>EFSA Journal >Scientific Opinion on applications (EFSA‐GMO‐RX‐40‐3‐2[8‐1a/20‐1a], EFSA‐GMO‐RX‐40‐3‐2) for renewal of authorisation for the continued marketing of (1) food containing, consisting of, or produced from genetically modified soybean 40‐3‐2; (2) feed containing, consisting of, or produced from soybean 40‐3‐2; (3) other products containing or consisting of soybean 40‐3‐2 with the exception of cultivation, all under Regulation (EC) No 1829/2003 from Monsanto
【24h】

Scientific Opinion on applications (EFSA‐GMO‐RX‐40‐3‐2[8‐1a/20‐1a], EFSA‐GMO‐RX‐40‐3‐2) for renewal of authorisation for the continued marketing of (1) food containing, consisting of, or produced from genetically modified soybean 40‐3‐2; (2) feed containing, consisting of, or produced from soybean 40‐3‐2; (3) other products containing or consisting of soybean 40‐3‐2 with the exception of cultivation, all under Regulation (EC) No 1829/2003 from Monsanto

机译:关于续展授权授权的申请的科学意见(EFSA-GMO-RX-40-3-3 [8-1a / 20-1a] ,EFSA-GMO-RX-40-3-2) (1)含有,由转基因大豆40-3-2组成或由其生产的食品的持续销售; (2)含有大豆40-3-2或由大豆40-3-2组成或由大豆40-3-2制成的饲料; (3)孟山都(EC)第1829/2003号法规所规定的除大豆外还包含大豆40-3-2或由大豆40-3-2组成的其他产品

获取原文
       

摘要

This scientific opinion is an evaluation of a risk assessment for the renewal of authorisations for continued marketing of the genetically modified herbicide tolerant soybean 40‐3‐2 (Unique Identifier MON‐?4?32‐6) for (1) food containing, consisting of, or produced from genetically modified (GM) soybean 40‐3‐2; (2) feed containing, consisting of, or produced from soybean 40‐3‐2; and (3) of other products containing or consisting of soybean 40‐3‐2 with the exception of cultivation. Soybean 40‐3‐2 has been developed for tolerance to glyphosate herbicides by the introduction, via particle gun acceleration technology, of a gene coding for 5‐enolpyruvylshikimate‐3‐phosphate synthase from Agrobacterium sp. strain CP4 (CP4 EPSPS). Molecular analyses indicated that soybean 40‐3‐2 contains one functional insert expressing CP4 EPSPS and a non‐functional insert consisting of a fragment of the CP4 EPSPS coding sequence. Updated bioinformatic analyses of the flanking sequences and the open reading frames spanning the insert‐plant DNA junctions and the levels of the newly expressed protein in soybean 40‐3‐2 did not raise any safety concern. The stability of the inserted DNA was confirmed over several generations. Available compositional and agronomic data show that soybean 40‐3‐2 is compositionally and agronomically equivalent to its conventional counterpart and to other commercial soybean varieties, except for expressing the CP4 EPSPS protein. It is estimated that the European consumers have been exposed to soybean 40‐3‐2 mainly via soybean oil Processed meal of soybean 40‐3‐2 has been given to farm animals in the EU at an estimated maximum dietary inclusion levels around 21% for broiler chickens, 18% for pigs, and 12% for dairy cattle. No adverse effects have been linked to these exposures. The safety assessment of the CP4 EPSPS protein expressed in soybean 40‐3‐2 and the whole soybean plant identified no concerns regarding potential toxicity and allergenicity of soybean 40‐3‐2. Considering the intended uses of soybean 40‐3‐2, which excludes cultivation within the European Union, no scientific assessment of potential environmental effects associated with cultivation of GM soybean 40‐3‐2 was required. In case of accidental release of viable grains produced by soybean 40‐3‐2 into the environment during transportation and processing, there are no indications of an increased likelihood of establishment and spread of feral soybean plants, except in the presence of the glyphosate herbicides. The EFSA GMO Panel considers unlikely that the recombinant DNA in soybean 40‐3‐2 transfers to bacteria and other micro‐organisms and that the risk caused by a rare but theoretically possible transfer of the recombinant epsps gene from soybean 40‐3‐2 to environmental microorganisms is regarded to be negligible due to the lack of a selective advantage in the context of its intended use that would be conferred. Taking into account the scope of the application, the rare occurrence of feral soybean plants and the low levels of exposure through other routes, indicate that the risk to non‐target organisms is extremely low. The scope of the monitoring plan provided by the applicant and the reporting intervals are in line with the intended uses of soybean 40‐3‐2 since cultivation is excluded. In conclusion, on the basis of the information considered in the original application, updated studies in the present applications, and other peer‐reviewed scientific data on soybean 40‐3‐2, the EFSA GMO Panel confirms that soybean 40‐3‐2 is as safe and nutritious as the conventional counterpart and other commercial soybean varieties.
机译:该科学见解是对继续销售转基因耐除草剂大豆40-3-2(Unique Identifier MON-4?32-6-6)用于以下产品的风险评估的评估:(1)含有以下成分的食品:转基因大豆40-3-2或由其生产; (2)含有大豆40-3-2或由大豆40-3-2组成或由大豆40-3-2制成的饲料; (3)其他含有或由大豆40-3-2组成的产品,但种植除外。通过使用粒子枪加速技术,引入了一种编码农杆菌属物种5-烯醇丙酮酸ki草酸酯-3-磷酸合酶的基因,从而开发出了对草甘膦除草剂具有耐受性的大豆40-3-2。菌株CP4(CP4 EPSPS)。分子分析表明,大豆40-3-2包含一个表达CP4 EPSPS的功能性插入片段和一个由CP4 EPSPS编码序列片段组成的非功能性插入片段。对侧翼序列和跨插入植物DNA连接的开放阅读框以及大豆40-3-2中新表达的蛋白质水平的最新生物信息学分析没有引起任何安全方面的关注。几代人都证实了插入DNA的稳定性。现有的成分和农艺学数据表明,除了表达CP4 EPSPS蛋白外,大豆40-3-2在成分和农学上与常规大豆和其他商品大豆品种相同。据估计,欧洲消费者主要通过豆油接触了大豆40-3-2,欧盟将其加工过的豆粕40-3-2用于欧盟的农场动物,估计其最大膳食摄入量约为21%。肉鸡,18%的猪和12%的奶牛。没有不利影响与这些暴露有关。对在大豆40-3-2和整个大豆植物中表达的CP4 EPSPS蛋白的安全性评估未发现对大豆40-3-2的潜在毒性和致敏性的担忧。考虑到大豆40-3-2的预期用途(不包括欧盟范围内的种植),因此无需对与种植大豆40-3-2的大豆相关的潜在环境影响进行科学评估。在运输和加工过程中,如果将大豆40-3-2产生的有生命力的谷物意外释放到环境中,则没有迹象表明野生大豆植株的建立和传播的可能性增加,除非存在草甘膦除草剂。 EFSA GMO专家组认为,大豆40-3-2中的重组DNA不太可能转移到细菌和其他微生物中,而且重组epsps基因从大豆40-3-2极少但理论上可能转移到大豆中的风险却很小由于在预期的用途中缺乏选择性优势,因此环境微生物被认为是微不足道的。考虑到应用范围,野生大豆植物的罕见发生和通过其他途径的低暴露水平表明对非目标生物的风险极低。申请人提供的监测计划的范围和报告间隔与大豆40-3-2的预期用途一致,因为不包括种植。总之,基于原始申请中考虑的信息,当前申请中的最新研究以及有关大豆40-3-2的其他同行评审科学数据,EFSA GMO专家组确认大豆40-3-2是与常规大豆和其他商业大豆品种一样安全又营养。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号